1 Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2018 Nov1;4(11): 1553-1568. doi: 10.1001/ jamaoncol.2018.2706.
2 Luo J, Chen JD, Chen Q, Yue LX, Zhou G, Lan C,et al. Contrast-enhanced ultrasound improved performance of breast imaging reporting and data system evaluation of critical breast lesions. World J Radiol. 2016 Jun 28;8(6): 610-7. doi: 10.4329/wjr.v8.i6.610.
3 Goldsmith SJ, Parsons W, Guiberteau MJ, Stern LH, Lanzkowsky L, Weigert J,et al.SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0. J Nucl Med Technol, 2010,38(4): 219- 224.doi: 10.2967/jnmt.110.082271. Epub 2010 Nov 5.
4 Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med, 2005, 353 (17): 1784– 1792. doi:10. 1056/NEJMoa050518.
5 Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA,et a1. Effects of age,breast density,ethnicity,and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis:review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology, 1998, 209(2): 511-8. doi:10. 1148/radiology.209.2.9807581
6 Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med, 2007, 356(3):227–236. doi: 10. 1056/NEJMoa062790
7 Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA , et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer I, 2006,98(17): 1204–14. doi:10.1093/jnci/djj331.
8 Yu X, Hu G, Zhang Z, Qiu F, Shao X, Wang X, et al. Retrospective and comparative analysis of 99m Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound,and magnetic resonance imaging for the detection of breast cancer in Chinese women. BMC Cancer, 2016, 16:450.doi:10.1186/ s12885-016-2537-1.
9 Kessler R, Sutcliffe JB, Bell L, Bradley YC, Anderson S, Banks KP. Negative predictive value of breast specific gamma imaging in low suspicion breast lesions: a potential means for reducing benign biopsies. Breast J. 2011;17(3):319–321. doi: 10.1111/j.1524- 4741. 2011.01077.x. Epub 2011 Apr 14.
10 Helvie MA, Paramagul C, Oberman HA, Adler DD.Invasive lobular carcinoma. Imaging features and clinical detection.Invest Radiol,1991,28(3):202-207.
11 Taskin F, Koseoglu K, Ozbas S, Erkus M, Karaman C. Sonographic features of histopathologically benign solid breast lesions that have been classified as BI-RADS 4 on sonography. J Clin Ultrasound. 2012 Jun;40(5):261-5.doi: 10.1002/jcu.21923. Epub 2012 Apr 17.
12 Tadwalkar RV, Rapelyea JA, Torrente J, Rechtman LR, Teal CB, McSwain AP,et a1. Breast-specific gamma imaging as all adjunct modality for the diagnosis of invasive breast cancer with correlation to tumor size and grade.Br JRadiol,2012,85(1014):e212-216.doi: 10.1259/bjr/34392802. Epub 2011 Jun 28.
13 Sampalis FS,Denis R, Picard D, Fleiszer D, Martin G, Nassif E, et al. International prospective evaluation of scintimammography with 99m-technetium sestamibi. Am J Surg, 2003, 185(6): 544-549.
14 Kim SJ,Kim IJ,Bae YT,Kim YK, Kim DS.Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer. Eur J Radiol, 2005, 53(2): 192-8.doi:10.1016/j.ejrad.2003.10.024.
15 Yoon JH, Jung HK, Lee JT, Ko KH. Shear-wave elastography in the diagnosis of solid breast masses: what leads to false-negative or false-positive results? Eur Radiol. 2013 Sep;23(9):2432-40. doi: 10.1007/ s00330-013-2854-6. Epub 2013 May 15.iscussion 445-7.
16 Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of pre-operative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007 May;142 (5):441-5; discussion 445-7.
17 Fallenberg EM, Schmitzberger FF, Amer H, Ingold-Heppner B, Balleyguier C, Diekmann F, et la. Contrast- enhanced spectral mammography vs. mammography and MRI-clinical performance in a multi-reader evaluation.
Eur Radiol. 2017 Jul;27(7):2752-2764. doi: 10.1007/s00330-016-4650-6. Epub 2016 Nov 28.
18 Sun Y, Wei W, Yang HW, Liu JL. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis. Eur J Nucl Med Mol Imaging, 2013, 40(3):450-63.doi:10.100 7/s00259-012-2279-5. Epub 2012 Nov 14.
19 Weigert JM, Bertrand ML, Lanzkowsky L, Stern LH, Kieper DA. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique. AJR Am J Roentgenol. 2012 Jan;198(1):W69-75. doi: 10.2214/ AJR. 10. 6105
20 Jones EA, Phan TD, Blanchard DA, Miley A. Breast-specific gamma-imaging: molecular imaging of the breast using 99mTc-sestamibi and a small-field-of-view gamma-camera. J Nucl Med Technol. 2009;37(4):201–5. doi: 10.2967/jnmt.109.063537. Epub 2009 Nov 13.
21 Park JS, Lee AY, Jung KP, Choi SJ, Lee SM, Kyun BS. Diagnostic performance of breast-specific gamma imaging (BSGI) for breast cancer: usefulness of dual-phase imaging with (99m)Tc-sestamibi. J Nucl Med Mol Imaging.2013;47(1):18–26. doi: 10.1007/s13139-012-0176-2. Epub 2012 Oct 13.